Browse > Article
http://dx.doi.org/10.6116/kjh.2018.33.5.19.

Drug-likeness and Oral bioavailability for Chemical Compounds of Medicinal Materials Constituting Oryeong-san  

Kim, Sang-Kyun (Future Medicine Division, Korea Institute of Oriential Medicine)
Lee, Seungho (Future Medicine Division, Korea Institute of Oriential Medicine)
Publication Information
The Korea Journal of Herbology / v.33, no.5, 2018 , pp. 19-37 More about this Journal
Abstract
Objectives : Oryeong-san was composed of Alismatis Rhizoma, Atractylodis Rhizoma Alba, Poria Sclerotium, Polyporus, Cinnamomi Cortex, and known to have hundreds of chemical compounds. The aim of this study was to screen chemical compounds constituting Oryeong-san with the drug-likeness and oral bioavailability from the analysis of their physicochemical properties. Methods : A list of chemical compounds of Oryeong-san was obtained from TM-MC(database of medicinal materials and chemical compounds in Northeast Asian traditional medicine). To remove redundant compounds, the SMILES (Simplified Molecular Input Line Entry System) strings of each compound were identified. All of the physicochemical properties for the compounds were calculated using the DruLiTo(Drug Likeness Tool). Drug-likeness was estimated by QED(Quantitative Estimate of Druglikeness) and OB(Oral bioavailability) was checked based on the Veber's rules. Results : A total of 475 compounds were obtained by eliminating duplication among 544 compounds of 5 medicinal materials. Analysis of the physicochemical properties revealed that the most common values were MW(molecular weight) 200~300 g/mol, ALOGP(octanol-water partition coefficient) 1~2, HBA(number of hydrogen bond acceptors) 0~1, HBD(number of hydrogen bond donors) 0, PSA(polar surface area) 0~50 angstrom, ROTB(number of rotatable bonds) 1, AROM(number of aromatic rings) 0, and ALERT(number of structural alerts) 1. QED had 93% of the values between 0.2 and 0.7, and OB had 90% of the value of TRUE. Conclusions : We in this paper screened the candidate active compounds of Oryeong-san using the QED and Veber's rules. In the future, we will use the screening results to analyze the mechanism of Oryeong-san based on systems pharmacology.
Keywords
Oryeong-san; TM-MC; drug-likeness; oral bioavailability; compound;
Citations & Related Records
연도 인용수 순위
  • Reference
1 한의과대학 방제학교수 공편저. 방제학. 서울:영림사; 2003, pp. 504-6.
2 Lee YJ, Lee SM, Cui X, Yoon JJ, Oh HC, Kim YC, Park MC, Kang DG, Lee HS. Quantitative evaluation of Oryeongsan and its action on water regulation in renal inner medullary collecting duct cells. Journal of Ethnopharmacology. 2016 ; 185:310-8.   DOI
3 Zhao S, Iyengar R. Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action. Annu Rev Pharmacol Toxicol. 2012 ; 52:505-21.   DOI
4 Yao Y, Zhang X, Wang Z, Zheng C, Li P, Huang C, Tao W, Xiao W, Wang Y, Huang L, Yang L. Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. Journal of Ethnopharmacology. 2013 ; 150(2):619-38.   DOI
5 Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL. Quantifying the chemical beauty of drugs. Nature Chemistry. 2012 ; 4(2):90-98.   DOI
6 Ohno K, Nagahara Y, Tsunoyama K, Orita M. Are There Differences between Launched Drugs, Clinical Candidates, and Commercially Available Compounds?. Journal of Chemical Information and Modeling. 2010 ; 50(5):815-21.   DOI
7 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997 ; 23: 3-25.   DOI
8 Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002 ; 45:2615-2623.   DOI
9 Hou T, Wang J, Zhang W, Xu X. ADME Evaluation in Drug Discovery. 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules?. J. Chem. Inf. Model. 2007 ; 47:460-463.   DOI
10 Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Ling Y. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability. International Journal of Molecular Sciences. 2012 ; 13:6964-82.   DOI
11 TM-MC [cited 2018 Jun 11]. Available from : URL : http://informatics.kiom.re.kr/compound/
12 SMILES [cited 2018 Jun 11]. Available from : URL : https://en.wikipedia.org/wiki/Simplified_molecular-input_line-entry_system
13 Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH. PubChem Substance and Compound databases. Nucleic Acids Res. 2016 ; 44(D1):D1202-13.   DOI
14 ChemDraw Professional v15 [cited 2018 Jun 11]. Available from : URL : http://www.cambridgesoft.com/Ensemble_for_Chemistry/ChemDraw/ChemDrawProfessional/Default.aspx
15 Hasada K, Yoshida T, Yamazaki T, Sugimoto N, Nishimura T, Nagatsu A, Mizukami H. Quantitative determination of atractylon in Atractylodis Rhizoma and Atractylodis Lanceae Rhizoma by 1H-NMR spectroscopy, Journal of Natural Medicines. 2010 ; 64(2):161-6.   DOI
16 Rayan A, Marcus D, Goldblum A. Predicting Oral Druglikeness by Iterative Stochastic Elimination. Journal of Chemical Information and Modeling. 2010 ; 50(3):437-45.   DOI
17 O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. Journal of Cheminformatics ; 2011 ; 3:33.   DOI
18 DruLiTo [cited 2018 Jun 11]. Available from : URL : http://www.niper.gov.in/pi_dev_tools/DruLiToWeb/DruLiTo_index.html
19 Ministry of Food and Drug Safety. The Korean Pharmacopoeia. Tenth Edition. 2014
20 Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia, 2010 English edition, 2010.
21 STITCH [cited 2018 Jun 25]. Available from : URL : http://stitch.embl.de
22 BindingDB [cited 2018 Jun 25]. Available from : URL : https://www.bindingdb.org/bind/index.jsp